9 RESULTS
COMMENT In Finland, we are widely using biomarkers of AD in clinical work, in particular MRI and CSF biomarkers. The new framework emphasizing the biomarkers irrespective of clinical symptoms in detecting AD early in research settings is very welcome. These are ...
COMMENT This is the first paper to show (11)C-PiB binding in PET in hereditary cerebral amyloid angiopathy and APP locus duplication. The paper reports increased uptake of (11)C-PiB in the striatum and the posterior cingulate in two cases with APP duplication, ...
COMMENT This paper reports an Aβ ligand (18)F-BAY94-9172 that, due to the half-life of (18)F, is suitable for clinical use. This is an important study and good news for clinicians. hilkka.soininen 0 ...
COMMENT One of the few papers focusing on health economic aspects of non-pharmacological therapy of dementia. hilkka.soininen 0 ...
COMMENT Using a surface-based hippocampal analysis, the authors analyzed the structural magnetic resonance hippocampal data of 31 amnestic MCI and 34 Alzheimer's disease subjects. The data showed differences between MCI and AD subjects in hippocampal ...
COMMENT This paper provides interesting data on familial AD, PS1 mutation carriers. Increased memory-related brain activity was detected in fMRI in young mutation carriers, suggesting a compensatory effort to overcome developing neural dysfunction, while middle ...
COMMENT This paper from colleagues from Washington University School of Medicine, St. Louis, reports interesting data showing that accelerated weight loss may precede diagnosis of Alzheimer disease. Data are based on a longitudinal study with follow-up time of 6 ...
COMMENT Follow-up data of prognosis in a large series of MCI subjects. hilkka.soininen 0 ...
COMMENT New data from immunization studies. hilkka.soininen 0 ...
